Abstract
Netilmicin, a new semisynthetic aminoglycoside antibiotic, was used to treat 41 infections in 38 patients. The outcome of four infections could not be evaluated: two patients received inadequate therapy and two did not have gram-negative infections. Clinical improvement occurred in 36 (97%) of the 37 gram-negative infections, and bacteriologic cure occurred in 30 (86%) of the 35 evaluable infections. Therapeutic serum concentrations of netilmicin were readily achieved by both intramuscular and intravenous routes. Reversible ototoxic effects occurred in 1 (3%) of 35 courses of therapy evaluated, reversible nephrotoxic effects occurred in 5 (14%) of 36 courses and mild reversible alterations in liver function occurred in 3 (19%) of 34 courses. Netilmicin appears to be effective and safe in the treatment of aerobic gram-negative infections.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
- Bowman R. L., Silverblatt F. J., Kaloyanides G. J. Comparison of the nephrotoxicity of netilmicin and gentamicin in rats. Antimicrob Agents Chemother. 1977 Oct;12(4):474–478. doi: 10.1128/aac.12.4.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Briedis D. J., Robson H. G. Comparative activity of netilmicin, gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa and Enterobacteriaceae. Antimicrob Agents Chemother. 1976 Oct;10(4):592–597. doi: 10.1128/aac.10.4.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dahlgren J. G., Anderson E. T., Hewitt W. L. Gentamicin blood levels: a guide to nephrotoxicity. Antimicrob Agents Chemother. 1975 Jul;8(1):58–62. doi: 10.1128/aac.8.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klastersky J., Meunier-Carpentier F., Coppens-Kahan L., Daneau D., Prevost J. M. Clinical and bacteriological evaluation of netilmicin in gram-negative infections. Antimicrob Agents Chemother. 1977 Oct;12(4):503–509. doi: 10.1128/aac.12.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Luft F. C., Yum M. N., Kleit S. A. Comparative nephrotoxicities of netilmicin and gentamicin in rats. Antimicrob Agents Chemother. 1976 Nov;10(5):845–849. doi: 10.1128/aac.10.5.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marrie T. J., Gurwith M. J., Ronald A. R., Stiver H. G., Lank B., Fox L. Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms. Can Med Assoc J. 1977 Jul 23;117(2):138–143. [PMC free article] [PubMed] [Google Scholar]
- Miller G. H., Arcieri G., Weinstein M. J., Waitz J. A. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Nov;10(5):827–836. doi: 10.1128/aac.10.5.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Panwalker A. P., Malow J. B., Zimelis V. M., Jackson G. G. Netilmicin: clinical efficacy, tolerance, and toxicity. Antimicrob Agents Chemother. 1978 Feb;13(2):170–176. doi: 10.1128/aac.13.2.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rahal J. J., Jr, Simberkoff M. S., Kagan K., Moldover N. H. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother. 1976 Apr;9(4):595–599. doi: 10.1128/aac.9.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith C. R., Baughman K. L., Edwards C. Q., Rogers J. F., Lietman P. S. Controlled comparison of amikacin and gentamicin. N Engl J Med. 1977 Feb 17;296(7):349–353. doi: 10.1056/NEJM197702172960701. [DOI] [PubMed] [Google Scholar]
- Welling P. G., Baumueller A., Lau C. C., Madsen P. O. Netilmicin pharmacokinetics after single intravenous doses to elderly male patients. Antimicrob Agents Chemother. 1977 Sep;12(3):328–334. doi: 10.1128/aac.12.3.328. [DOI] [PMC free article] [PubMed] [Google Scholar]